These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8043542)

  • 21. Flow cytometrical DNA- and clinical parameters in the prediction of prognosis in stage I-II endometrial carcinoma.
    Lindahl B; Gullberg B
    Anticancer Res; 1991; 11(1):397-401. PubMed ID: 2018376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Residual myometrial invasion after intracavitary irradiation of endometrial adenocarcinoma stages I and II. Relations to DNA content and S-phase rate.
    Wagenius G; Strang P; Boman K; Tribukait B; Stendahl U
    In Vivo; 1988; 2(3-4):243-5. PubMed ID: 2979839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer.
    Chattopadhyay S; Galaal KA; Patel A; Fisher A; Nayar A; Cross P; Naik R
    BJOG; 2012 Sep; 119(10):1162-70. PubMed ID: 22804815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Value of Preoperative CA 125 Levels in Prediction of Myometrial Invasion in Patients with Early-stage Endometrioid- type Endometrial Cancer.
    Atguden Z; Yildiz A; Aksut H; Yalcin SE; Yalcin Y; Uysal D; Yetimalar H
    Asian Pac J Cancer Prev; 2016; 17(2):497-501. PubMed ID: 26925634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum CA 125 levels and sonography in the pre-operative assessment of myometrial invasion of endometrial cancer.
    Lehtovirta P; Cacciatore B; Ylöstalo P
    Br J Obstet Gynaecol; 1994 Jun; 101(6):532-5. PubMed ID: 8018645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combined treatment and prognostic factors for stage III and IV endometrial carcinoma].
    Ren YL; Wang HY; Shi DR; Yang WT; Sun Z; Chen Y
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):523-7. PubMed ID: 19080517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of high-risk groups in endometrial carcinoma stage I-II. A combination of DNA- and steroid receptor-measurements identifies early deaths from the disease.
    Lindahl B; Ranstam J; Norgren A; Willén R
    Anticancer Res; 1995; 15(3):1095-100. PubMed ID: 7645932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
    Baak JP; Snijders W; van Diermen B; van Diest PJ; Diepenhorst FW; Benraadt J
    J Clin Oncol; 2003 Nov; 21(22):4214-21. PubMed ID: 14615450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative and intraoperative assessment of myometrial invasion and histologic grade in endometrial cancer: role of magnetic resonance imaging and frozen section.
    Sanjuán A; Cobo T; Pahisa J; Escaramís G; Ordi J; Ayuso JR; Garcia S; Hernández S; Torné A; Martínez Román S; Lejárcegui JA; Vanrell JA
    Int J Gynecol Cancer; 2006; 16(1):385-90. PubMed ID: 16445663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective clinical study of the association between plasma level of free IGF-1 and myometrial invasion min patients with endometrial adenocarcinoma.
    Baloglu A; Bezircioglu I; Cetinkaya B; Hicyilmaz L
    Ginekol Pol; 2010 Jul; 81(7):501-5. PubMed ID: 20825050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of myometrial invasion on prognostic factors and survival analysis in endometrial carcinoma.
    Dane C; Bakir S
    Afr Health Sci; 2019 Dec; 19(4):3235-3241. PubMed ID: 32127901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative evaluation of endometrial carcinoma by contrast-enhanced ultrasonography.
    Song Y; Yang J; Liu Z; Shen K
    BJOG; 2009 Jan; 116(2):294-8; discussion 298-9. PubMed ID: 19076961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic indices in endometrial adenocarcinoma stages I and II. A study based on clinical, histopathological and flow cytometric variables.
    Wagenius G; Strang P; Bergström R; Stendahl U; Tribukait B
    Anticancer Res; 1991; 11(6):2137-42. PubMed ID: 1776852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating the depth of myometrial involvement by endometrial carcinoma: efficacy of transvaginal sonography vs MR imaging.
    DelMaschio A; Vanzulli A; Sironi S; Spagnolo D; Belloni C; Garancini P; Taccagni GL
    AJR Am J Roentgenol; 1993 Mar; 160(3):533-8. PubMed ID: 8430547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peritumorous lymph-vascular invasion, grade of histologic differentiation, and myometrial infiltration as prognostic factors of endometrial carcinoma.
    De Góis NM; Martins NV; Abrão FS; De Lima GR; Alves AC
    Rev Paul Med; 1993; 111(3):385-90. PubMed ID: 8108630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliability of magnetic resonance imaging in assessing myometrial invasion absence in endometrial carcinoma.
    Suh DS; Kim JK; Kim KR; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Acta Obstet Gynecol Scand; 2009; 88(9):990-3. PubMed ID: 19636979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer.
    Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S
    Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas.
    Ytre-Hauge S; Husby JA; Magnussen IJ; Werner HM; Salvesen ØO; Bjørge L; Trovik J; Stefansson IM; Salvesen HB; Haldorsen IS
    Int J Gynecol Cancer; 2015 Mar; 25(3):459-66. PubMed ID: 25628109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multivariate analysis of assessment of myometrial invasion of endometrial carcinoma by magnetic resonance imaging.
    Atsukawa H; Sasaki H; Tada S
    Gynecol Oncol; 1994 Sep; 54(3):298-306. PubMed ID: 8088606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.